Stephen I Stone

Dr. Stephen I Stone

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
DADamien Abreu
Damien Abreu
SSStephen I Stone
Stephen I Stone
TPToni S. Pearson
Toni S. Pearson
RBRobert C. Bucelli
Robert C. Bucelli
ASAshley N. Simpson
Ashley N. Simpson
FUFumihiko Urano
Fumihiko Urano
BACKGROUND: Wolfram syndrome is a rare ER disorder characterized by insulin-dependent diabetes mellitus, optic nerve atrophy, and progressive neurodegeneration. Although there is no treatment for Wolfram syndrome, preclinical studies in cell and rodent models suggest that therapeutic strategies targeting ER calcium homeostasis, including dantrolene sodium, may be beneficial. METHODS: Based on results from preclinical studies on dantrolene sodium and ongoing longitudinal studies, we assembled what we believe is the first-ever clinical trial in pediatric and adult Wolfram syndrome patients with an open-label phase Ib/IIa trial design. The primary objective was to assess the safety and tolerability of dantrolene sodium in adult and pediatric Wolfram syndrome patients. Secondary objectives were to evaluate the efficacy of dantrolene sodium on residual pancreatic β cell functions, visual acuity, quality-of-life measures related to vision, and neurological functions. RESULTS: Dantrolene sodium was well tolerated by Wolfram syndrome patients. Overall, β cell functions were not significantly improved, but there was a significant correlation between baseline β cell functions and change in β cell responsiveness ( R 2 , P = 0.004) after 6-month dantrolene therapy. Visual acuity and neurological functions were not improved by 6-month dantrolene sodium. Markers of inflammatory cytokines and oxidative stress, such as IFN-γ, IL-1β, TNF-α, and isoprostane, were elevated in subjects. CONCLUSION: This study justifies further investigation into using dantrolene sodium and other small molecules targeting the ER for treatment of Wolfram syndrome. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02829268 FUNDING: NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK112921, DK113487, DK020579), NIH/National Center for Advancing Translational Sciences (NCATS) (TR002065, TR000448), NIH training grant (F30DK111070), Silberman Fund, Ellie White Foundation, Snow Foundation, Unravel Wolfram Syndrome Fund, Stowe Fund, Eye Hope Foundation, Feiock Fund, Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from NIH/NCATS, Bursky Center for Human Immunology & Immunotherapy Programs.

6 April 2007 in Current Genetics
Verified
Journal Article
Closed access
PDF file
YVYakov A. Vitrenko
Yakov A. Vitrenko
MPMariana E. Pavon
Mariana E. Pavon
SSStephen I Stone
Stephen I Stone
SLSusan W. Liebman
Susan W. Liebman

8 May 2020 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
SSStephen I Stone
Stephen I Stone
DADamien Abreu
Damien Abreu
JMJanet B. McGill
Janet B. McGill
FUFumihiko Urano
Fumihiko Urano

8 February 2024 in Diabetes Care
Verified
Journal Article
Open access
PDF file
SSStephen I Stone
Stephen I Stone
ABAshok Balasubramanyam
Ashok Balasubramanyam
JPJennifer E. Posey
Jennifer E. Posey
As our understanding of the pathophysiology of diabetes evolves, we increasingly recognize that many patients may have a form of diabetes that does not neatly fit with a diagnosis of either type 1 or type 2 diabetes. The discovery and description of these forms of “atypical diabetes” have led to major contributions to our collective understanding of the basic biology that drives insulin secretion, insulin resistance, and islet autoimmunity. These discoveries now pave the way to a better classification of diabetes based on distinct endotypes. In this review, we highlight the key biological and clinical insights that can be gained from studying known forms of atypical diabetes. Additionally, we provide a framework for identification of patients with atypical diabetes based on their clinical, metabolic, and molecular features. Helpful clinical and genetic resources for evaluating patients suspected of having atypical diabetes are provided. Therefore, appreciating the various endotypes associated with atypical diabetes will enhance diagnostic accuracy and facilitate targeted treatment decisions.

26 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SSStephen I Stone
Stephen I Stone
DADamien Abreu
Damien Abreu
JMJana Mahadevan
Jana Mahadevan
RARie Asada
Rie Asada
KKKelly Kries
Kelly Kries
FUFumihiko Urano
Fumihiko Urano
Endoplasmic reticulum (ER) stress in beta cells is an important pathogenic component of both type 1 and type 2 diabetes mellitus, as well as genetic forms of diabetes, especially Wolfram syndrome. However, there are currently no convenient ways to assess ER stress in beta cells, raising the need for circulating ER stress markers indicative of beta cell health. Here we show that pancreatic stone protein/regenerating protein (PSP/reg) is a potential biomarker for ER stressed beta cells. PSP/reg levels are elevated in cell culture and mouse models of Wolfram syndrome, a prototype of ER stress-induced diabetes. Moreover, PSP/reg expression is induced by the canonical chemical inducers of ER stress, tunicamycin and thapsigargin. Circulating PSP/reg levels are also increased in some patients with Wolfram syndrome. Our results therefore reveal PSP/reg as a potential biomarker for beta cells under chronic ER stress, as is the case in Wolfram syndrome.

20 February 2018 in Endocrinology, Diabetes & Metabolism Case Reports
Verified
Journal Article
Open access
PDF file
NZNicholas R Zessis
Nicholas R Zessis
JNJennifer L Nicholas
Jennifer L Nicholas
SSStephen I Stone
Stephen I Stone
Summary: Bilateral adrenal hemorrhages rarely occur during the neonatal period and are often associated with traumatic vaginal deliveries. However, the adrenal gland has highly regenerative capabilities and adrenal insufficiency typically resolves over time. We evaluated a newborn female after experiencing fetal macrosomia and a traumatic vaginal delivery. She developed acidosis and acute renal injury. Large adrenal hemorrhages were noted bilaterally on ultrasound, and she was diagnosed with adrenal insufficiency based on characteristic electrolyte changes and a low cortisol (4.2 µg/dL). On follow-up testing, this patient was unable to be weaned off of hydrocortisone or fludrocortisone despite resolution of hemorrhages on ultrasound. Providers should consider bilateral adrenal hemorrhage when evaluating critically ill neonates after a traumatic delivery. In extreme cases, this may be a persistent process. Learning points: Risk factors for adrenal hemorrhage include fetal macrosomia, traumatic vaginal delivery and critical acidemia. Signs of adrenal hemorrhage include jaundice, flank mass, skin discoloration or scrotal hematoma. Adrenal insufficiency often is a transient process when related to adrenal hemorrhage. Severe adrenal hemorrhages can occur in the absence of symptoms. Though rare, persistent adrenal insufficiency may occur in extremely severe cases of bilateral adrenal hemorrhage. Consider adrenal hemorrhage when evaluating a neonate for shock in the absence of an infectious etiology.